Clinical Trial Update: A Study of KHK4827 in Subjects With Palmoplantar Pustulosis [Phase 3]

View source ↗

Summary

Phase 3 trial of KHK4827 in palmoplantar pustulosis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Palmoplantar Pustulosis

Drugs mentioned

• KHK4827

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Palmoplantar Pustulosis | Phase 3 | Status: COMPLETED